- Home
- ALZN vs MKZR Comparison
ALZN vs MKZR Comparison
Compare ALZN & MKZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALZN
- MKZR
- Stock Information
- Founded
- ALZN 2016
- MKZR 2012
- Country
- ALZN United States
- MKZR United States
- Employees
- ALZN N/A
- MKZR N/A
- Industry
- ALZN Medicinal Chemicals and Botanical Products
- MKZR
- Sector
- ALZN Health Care
- MKZR
- Exchange
- ALZN Nasdaq
- MKZR Nasdaq
- Market Cap
- ALZN 9.0M
- MKZR 10.3M
- IPO Year
- ALZN 2021
- MKZR N/A
- Fundamental
- Price
- ALZN $2.32
- MKZR $4.14
- Analyst Decision
- ALZN Strong Buy
- MKZR
- Analyst Count
- ALZN 1
- MKZR 0
- Target Price
- ALZN $42.00
- MKZR N/A
- AVG Volume (30 Days)
- ALZN 100.6K
- MKZR 37.9K
- Earning Date
- ALZN 12-11-2025
- MKZR 11-14-2025
- Dividend Yield
- ALZN N/A
- MKZR 21.64%
- EPS Growth
- ALZN N/A
- MKZR N/A
- EPS
- ALZN N/A
- MKZR N/A
- Revenue
- ALZN N/A
- MKZR $21,294,932.00
- Revenue This Year
- ALZN N/A
- MKZR N/A
- Revenue Next Year
- ALZN N/A
- MKZR N/A
- P/E Ratio
- ALZN N/A
- MKZR N/A
- Revenue Growth
- ALZN N/A
- MKZR 21.25
- 52 Week Low
- ALZN $2.06
- MKZR $3.89
- 52 Week High
- ALZN $12.87
- MKZR $50.00
- Technical
- Relative Strength Index (RSI)
- ALZN 45.72
- MKZR 32.03
- Support Level
- ALZN $2.21
- MKZR $4.77
- Resistance Level
- ALZN $2.61
- MKZR $4.90
- Average True Range (ATR)
- ALZN 0.16
- MKZR 0.39
- MACD
- ALZN -0.01
- MKZR -0.07
- Stochastic Oscillator
- ALZN 32.29
- MKZR 0.00
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About MKZR MacKenzie Realty Capital Inc.
Mackenzie Realty Capital Inc is a company which is a Real estate investment trust (REIT). The company has one reportable segment, income-producing real estate properties which consists of activities related to investing in real estate.